APA

Ginhoux F., Turbant S., Gross D. A., Poupiot J., Marais T., Lone Y., Lemonnier F. A., Firat H., Perez N., Danos O. & Davoust J. (20050216). HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system. : Molecular therapy : the journal of the American Society of Gene Therapy.

Chicago

Ginhoux F, Turbant S, Gross D A, Poupiot J, Marais T, Lone Y, Lemonnier F A, Firat H, Perez N, Danos O and Davoust J. 20050216. HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system. : Molecular therapy : the journal of the American Society of Gene Therapy.

Harvard

Ginhoux F., Turbant S., Gross D. A., Poupiot J., Marais T., Lone Y., Lemonnier F. A., Firat H., Perez N., Danos O. and Davoust J. (20050216). HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system. : Molecular therapy : the journal of the American Society of Gene Therapy.

MLA

Ginhoux F, Turbant S, Gross D A, Poupiot J, Marais T, Lone Y, Lemonnier F A, Firat H, Perez N, Danos O and Davoust J. HLA-A*0201-restricted cytolytic responses to the rtTA transactivator dominant and cryptic epitopes compromise transgene expression induced by the tetracycline on system. : Molecular therapy : the journal of the American Society of Gene Therapy. 20050216.